{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:03:26Z","timestamp":1790726606891,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P30NS047101"],"award-info":[{"award-number":["P30NS047101"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023741","name":"University of California-San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rpth.2026.103436","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:45:08Z","timestamp":1774514708000},"page":"103436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effects of recombinant human activated factor VII and tranexamic acid on traumatic bleeding and mortality in mice"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-4546","authenticated-orcid":false,"given":"Bilgimol","family":"Chumappumkal Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Andres","family":"De Pablo-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicca","family":"Falah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Wentzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Lora Cacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Frias-Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"von Drygalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103436_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00068-025-02824-8","article-title":"Impact of trauma on society","volume":"51","author":"Halvachizadeh","year":"2025","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1016\/j.rpth.2026.103436_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/cc3779","article-title":"The epidemiology and modern management of traumatic hemorrhage: US and international perspectives","volume":"9","author":"Kauvar","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.rpth.2026.103436_bib3","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc12685","article-title":"Management of bleeding and coagulopathy following major trauma: an updated European guideline","volume":"17","author":"Spahn","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.rpth.2026.103436_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/TA.0000000000004170","article-title":"Trauma-induced coagulopathy: what you need to know","volume":"96","author":"Buzzard","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.rpth.2026.103436_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3390\/diagnostics15111435","article-title":"Trauma-induced coagulopathy: a review of specific molecular mechanisms","volume":"15","author":"Capponi","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.rpth.2026.103436_bib6","first-page":"319","article-title":"The acute coagulopathy of trauma is due to impaired initial thrombin generation but not clot formation or clot strength","volume":"170","author":"Harr","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.rpth.2026.103436_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/jth.14690","article-title":"Defining trauma-induced coagulopathy with respect to future implications for patient management: communication from the SSC of the ISTH","volume":"18","author":"Moore","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib8","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1111\/trf.16971","article-title":"Platelet dysfunction after trauma: from mechanisms to targeted treatment","volume":"62","author":"Sloos","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/j.rpth.2026.103436_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2022.10.017","article-title":"Hyperfibrinolysis drives mechanical instabilities in a simulated model of trauma induced coagulopathy","volume":"220","author":"Gosselin","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103436_bib10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0268-960X(15)30002-3","article-title":"Recombinant activated factor VII: 30 years of research and innovation","volume":"29","author":"Hedner","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2026.103436_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000338034","article-title":"Use of activated recombinant factor VII in severe bleeding - evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding","volume":"39","author":"Lau","year":"2012","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.rpth.2026.103436_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ACO.0b013e32832678c6","article-title":"The role of recombinant-activated factor VII in bleeding trauma patients","volume":"22","author":"Dutton","year":"2009","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.rpth.2026.103436_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e3181cc4378","article-title":"The use of recombinant activated FVII in postpartum hemorrhage","volume":"53","author":"Franchini","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.rpth.2026.103436_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102533","article-title":"Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis","volume":"8","author":"van der Bom","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-137-11-200212030-00009","article-title":"Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate","volume":"137","author":"Deveras","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.103436_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1538-7836.2003.00101.x","article-title":"Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin","volume":"1","author":"Chan","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jth.14644","article-title":"Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets","volume":"18","author":"Enoksson","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1538-7836.2005.01227.x","article-title":"Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count","volume":"3","author":"Lisman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0049-3848(89)90268-5","article-title":"Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor","volume":"56","author":"Telgt","year":"1989","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103436_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40268-015-0093-9","article-title":"Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery","volume":"15","author":"Omar","year":"2015","journal-title":"Drugs R D"},{"key":"10.1016\/j.rpth.2026.103436_bib21","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1186\/cc3784","article-title":"Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma","volume":"9","author":"Mohr","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.rpth.2026.103436_bib22","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.103436_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"J Trauma"},{"key":"10.1016\/j.rpth.2026.103436_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.annemergmed.2023.10.004","article-title":"Tranexamic acid for traumatic injury in the emergency setting: a systematic review and bias-adjusted meta-analysis of randomized controlled trials","volume":"83","author":"Fouche","year":"2024","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.rpth.2026.103436_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103436_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","article-title":"Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients","volume":"391","author":"Gayet-Ageron","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.103436_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102543","article-title":"Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid","volume":"8","author":"Joseph","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/bloodadvances.2021005257","article-title":"An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice","volume":"6","author":"Joseph","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.103436_bib29","doi-asserted-by":"crossref","DOI":"10.3791\/55554","article-title":"Uncontrolled hemorrhagic shock modeled via liver laceration in mice with real time hemodynamic monitoring","author":"Dyer","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.rpth.2026.103436_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2004.11.003","article-title":"Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study","volume":"116","author":"Petersen","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103436_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jss.2017.03.031","article-title":"Impact of tranexamic acid on coagulation and inflammation in murine models of traumatic brain injury and hemorrhage","volume":"215","author":"Boudreau","year":"2017","journal-title":"J Surg Res"},{"key":"10.1016\/j.rpth.2026.103436_bib32","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1111\/bcp.14767","article-title":"Population pharmacokinetics and pharmacodynamics of Tranexamic acid in women undergoing caesarean delivery","volume":"87","author":"Li","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2026.103436_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jcp.18.4.465","article-title":"Partial thromboplastin time test with kaolin. Normal range and modifications for the diagnosis of haemophilia and Christmas disease","volume":"18","author":"Matchett","year":"1965","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.rpth.2026.103436_bib34","first-page":"237","article-title":"[Rapid physiological coagulation method in determination of fibrinogen]","volume":"17","author":"Clauss","year":"1957","journal-title":"Acta Haematol"},{"key":"10.1016\/j.rpth.2026.103436_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/0023677214546509","article-title":"The effect of carbon dioxide flow rate on the euthanasia of laboratory mice","volume":"48","author":"Moody","year":"2014","journal-title":"Lab Anim"},{"key":"10.1016\/j.rpth.2026.103436_bib36","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/ATVBAHA.123.320367","article-title":"Mild hypoxia accelerates cerebral cavernous malformation disease through CX3CR1-CX3CL1 signaling","volume":"44","author":"Frias-Anaya","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.103436_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/ALN.0000000000001428","article-title":"Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy","volume":"126","author":"Davenport","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.rpth.2026.103436_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90492-0","article-title":"Disseminated intravascular coagulation immediately after trauma predicts a poor prognosis in severely injured patients","volume":"11","author":"Wada","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2026.103436_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rpth.2026.103436_bib40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jclinpath-2016-203854","article-title":"An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis","volume":"70","author":"Godier","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.rpth.2026.103436_bib41","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/jth.14552","article-title":"Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model","volume":"17","author":"Girish","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/srep00879","article-title":"Fibrin clots are equilibrium polymers that can be remodeled without proteolytic digestion","volume":"2","author":"Chernysh","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2026.103436_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1745-6215-13-87","article-title":"CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial","volume":"13","author":"Dewan","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.rpth.2026.103436_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40560-016-0200-1","article-title":"Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype","volume":"5","author":"Hayakawa","year":"2017","journal-title":"J Intensive Care"},{"key":"10.1016\/j.rpth.2026.103436_bib45","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/TA.0000000000001685","article-title":"Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin","volume":"83","author":"Barrett","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.rpth.2026.103436_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0049-3848(98)00121-2","article-title":"Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test","volume":"92","author":"Bach-Gansmo","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103436_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1054\/fipr.2000.0080","article-title":"Plasma granulocyte elastase levels and its relation to D-dimer in liver cirrhosis","volume":"14","author":"Song","year":"2000","journal-title":"Fibrinolysis Proteolysis"},{"key":"10.1016\/j.rpth.2026.103436_bib48","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1365-2516.2009.02073.x","article-title":"Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions","volume":"15","author":"Aljamali","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103436_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953195","article-title":"The role of neutrophil extracellular traps in acute lung injury","volume":"13","author":"Scozzi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2026.103436_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2022.05.007","article-title":"CT-001 is a rapid clearing factor VIIa with enhanced clearance and hemostatic activity for the treatment of acute bleeding in non-hemophilia settings","volume":"215","author":"Sim","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103436_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2516.2004.00925.x","article-title":"Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A","volume":"10","author":"Villar","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103436_bib52","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/j.1538-7836.2012.04917.x","article-title":"Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa","volume":"10","author":"Clark","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib53","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjsurg.2009.05.026","article-title":"Complications of recombinant activated human coagulation factor VII","volume":"198","author":"Howes","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.rpth.2026.103436_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/TA.0000000000004163","article-title":"When is it safe to start venous thromboembolism prophylaxis after blunt solid organ injury? A prospective American Association for the Surgery of Trauma multi-institutional trial","volume":"96","author":"Schellenberg","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.rpth.2026.103436_bib55","article-title":"Acute traumatic coagulopathy: what you should know, what is debated and what should come next","volume":"44","author":"James","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.rpth.2026.103436_bib56","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood.2020008417","article-title":"Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect","volume":"137","author":"Das","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103436_bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.blre.2014.12.004","article-title":"The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa","volume":"29","author":"Lisman","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2026.103436_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2026.103436_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis","volume":"344","author":"Ker","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2026.103436_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","article-title":"Tranexamic acid--an old drug still going strong and making a revival","volume":"135","author":"Tengborn","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103436_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.rpth.2026.103436_bib62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.15585\/mmwr.mm7014e1","article-title":"Provisional mortality data - United States, 2020","volume":"70","author":"Ahmad","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.rpth.2026.103436_bib63","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jth.14450","article-title":"Trauma-induced coagulopathy: the past, present, and future","volume":"17","author":"Kornblith","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12530","article-title":"In vitro characterization of CT-001-a short-acting factor VIIa with enhanced prohemostatic activity","volume":"5","author":"Sim","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib65","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11095-016-1895-3","article-title":"Safety, stability and pharmacokinetic properties of (super)factor Va, a novel engineered coagulation factor V for treatment of severe bleeding","volume":"33","author":"Gale","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.rpth.2026.103436_bib66","first-page":"638","article-title":"Acute traumatic coagulopathy","volume":"20","author":"Cap","year":"2014","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.rpth.2026.103436_bib67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/TA.0000000000004079","article-title":"Rapid clearing CT-001 restored hemostasis in mice with coagulopathy induced by activated protein C","volume":"96","author":"Sim","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.rpth.2026.103436_bib68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1160\/th15-07-0525","article-title":"Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and factor VIIa","volume":"115","author":"Bhat","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103436_bib69","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2003-05-1369","article-title":"Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A","volume":"102","author":"Tranholm","year":"2003","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:14:52Z","timestamp":1790723692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2475037926000944"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103436","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of recombinant human activated factor VII and tranexamic acid on traumatic bleeding and mortality in mice","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103436"}}